Stock Analiz

DR Reddys Laboratories Ltd. (RDY) earnings: date, estimates and history

Price $14.74 · data as of November 13, 2026

Next earnings report

Next reportNot announced yet
Quarterending December 31, 2026
EPS estimate—
Revenue estimate—
Expected EPS growth—

The date appears here once DR Reddys Laboratories confirms it, usually two to four weeks before the report.

Track record

Beat EPS estimates1 of 4
Average surprise−29.4%
Average move on report day±3.6%

DR Reddys Laboratories beat the consensus earnings estimate in 1 of its last 4 reports, by −29.4% on average. On report days the stock moved 3.6% on average, up or down.

Earnings history

ReportedEPS estimateEPS actualSurpriseRevenueRevenue growthStock move
October 23, 2026
Sep/2026
$0.16$0.12−25.0%——+3.9%
July 22, 2026
Jun/2026
$0.17$0.06−64.7%——−6.0%
May 12, 2026
Mar/2026
$0.09$0.06−33.3%——−1.1%
January 21, 2026
Dec/2025
$0.16$0.16———+5.9%
October 24, 2025
Sep/2025
$0.18$0.19+5.6%——−1.0%

EPS as compared with analyst estimates (reported EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.

Frequently asked questions

When is DR Reddys Laboratories’s next earnings date?

DR Reddys Laboratories has not confirmed its next report date yet. Its last report was on October 23, 2026.

Did DR Reddys Laboratories beat earnings last quarter?

No, it reported EPS of $0.12 on October 23, 2026 against an estimate of $0.16 (a −25.0% surprise), and the stock moved +3.9% the next trading day.

Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar